1
|
Dymek M, García-Celma MJ, Escribano-Ferrer E, Warszycki D, Kaźmierski S, Skoczylas Ł, Tabaszewska M, Sikora E. Tripeptide-Loaded Liposomes as Multifunctional Components in Topical Formulations. Int J Mol Sci 2025; 26:5321. [PMID: 40508130 PMCID: PMC12154373 DOI: 10.3390/ijms26115321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2025] [Revised: 05/18/2025] [Accepted: 05/30/2025] [Indexed: 06/16/2025] Open
Abstract
Modern dermocosmetics combine the effectiveness of active substances with the benefits of percutaneous penetration enhancers to address skin issues such as hyperpigmentation. In this study, three bioactive tripeptides (with amino acid sequences CSF, CVL, and CSN) with previously confirmed tyrosinase inhibition activity were synthesized using the solid-phase synthesis method. The structures of the obtained peptides were determined. In addition, elastase in silico and in vitro inhibition assays were carried out. The tripeptides were subsequently encapsulated into liposomes, for which key physicochemical parameters were determined, including size, zeta potential, and encapsulation efficiency. The average diameter of the prepared liposomes was approximately 100 nm across all samples. The prepared carriers were found to be stable and exhibited no cytotoxicity toward reconstructed human epidermis cells. The peptides achieved an encapsulation efficiency of approximately 20-30%, with no significant differences observed between the cationic and anionic vesicles. Liposomes containing the CSF tripeptide, which showed the strongest tyrosinase-inhibiting effect, did not transport the peptide through the human skin in an ex vivo assay to permit quantification in the receptor solution, but facilitated penetration and retention of the tripeptide within the epidermis (4.65 ± 1.81 μg/cm2). These findings suggest that the prepared liposomes may serve as valuable carriers of bioactive tripeptides in anti-aging cosmetics.
Collapse
Affiliation(s)
- Michał Dymek
- CUT Doctoral School, Faculty of Chemical Engineering and Technology, Cracow University of Technology, 31-155 Kraków, Poland
| | - Maria José García-Celma
- Pharmaceutical Nanotechnology Group, Department of Pharmacy, Pharmaceutical Technology and Physical-Chemistry, University of Barcelona, E-08028 Barcelona, Spain
| | - Elvira Escribano-Ferrer
- Biopharmaceutics and Pharmacokinetics Unit, Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, E-08028 Barcelona, Spain
| | - Dawid Warszycki
- Department of Medicinal Chemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, Poland
| | - Sławomir Kaźmierski
- Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, 90-363 Łódź, Poland
| | - Łukasz Skoczylas
- Department of Plant Product Technology and Nutrition Hygiene, Faculty of Food Technology, University of Agriculture in Kraków, 30-149 Kraków, Poland
| | - Małgorzata Tabaszewska
- Department of Plant Product Technology and Nutrition Hygiene, Faculty of Food Technology, University of Agriculture in Kraków, 30-149 Kraków, Poland
- Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, 71-460 Szczecin, Poland
| | - Elżbieta Sikora
- Faculty of Chemical Engineering and Technology, Cracow University of Technology, 31-155 Kraków, Poland
| |
Collapse
|
2
|
Somboon K, Chng CP, Huang C, Gupta S. Enhancing Niacinamide Skin Penetration via Other Skin Brightening Agents: A Molecular Dynamics Simulation Study. Int J Mol Sci 2025; 26:1555. [PMID: 40004021 PMCID: PMC11855608 DOI: 10.3390/ijms26041555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2025] [Revised: 02/10/2025] [Accepted: 02/11/2025] [Indexed: 02/27/2025] Open
Abstract
Niacinamide, a derivative of vitamin B3, has been shown to reduce skin pigmentation (i.e., acting as a brightening agent) and inflammatory responses such as dermatitis and acne vulgaris. However, niacinamide is a hydrophilic compound and poor partitioning to the lipid matrix in the uppermost layer of the skin (the stratum corneum or SC) limits its delivery to the skin. This necessitates the use of penetration enhancers to increase its bio-availability. In this study, we used computer simulations to investigate the skin penetration of niacinamide alone and in combination with other brightening agents that are also shown to be skin penetration enhancers, namely undecylenoyl phenylalanine (Sepiwhite®), bisabolol, or sucrose dilaurate. Molecular dynamics simulations were performed to reveal molecular interactions of these brightening agents with a lipid bilayer model that mimics the SC lipid matrix. We observed minimal penetration of niacinamide into the SC lipid bilayer when applied alone or in combination with any one of the three compounds. However, when all three compounds were combined, a notable increase in penetration was observed. We showed a 32% increase in the niacinamide diffusivity in the presence of three other brightening agents, which also work as penetration enhancers for niacinamide. These findings suggest that formulations containing multiple brightening agents, which work as penetration enhancers, may improve skin penetration of niacinamide and enhance the effectiveness of the treatment.
Collapse
Affiliation(s)
- Kamolrat Somboon
- Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, #07-01 Matrix, Singapore 138671, Singapore;
| | - Choon-Peng Chng
- School of Mechanical and Aerospace Engineering, Nanyang Technological University, Singapore 639798, Singapore; (C.-P.C.); (C.H.)
| | - Changjin Huang
- School of Mechanical and Aerospace Engineering, Nanyang Technological University, Singapore 639798, Singapore; (C.-P.C.); (C.H.)
| | - Shikhar Gupta
- P&G Singapore Innovation Center (SgIC), 70 Biopolis Street, Singapore 138547, Singapore
| |
Collapse
|
3
|
Bácskay I, Hosszú Z, Budai I, Ujhelyi Z, Fehér P, Kósa D, Haimhoffer Á, Pető Á. Formulation and Evaluation of Transdermal Patches Containing BGP-15. Pharmaceutics 2023; 16:36. [PMID: 38258047 PMCID: PMC10819821 DOI: 10.3390/pharmaceutics16010036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2023] [Revised: 12/19/2023] [Accepted: 12/25/2023] [Indexed: 01/24/2024] Open
Abstract
BGP-15 is an active ingredient with many advantages, e.g., beneficial cardiovascular and anti-inflammatory effects. The transdermal administration of BGP-15 has great potential, which has not been investigated yet, despite the fact that it is a non-invasive and safe form of treatment. The aim of our study was to formulate transdermal patches containing BGP-15 and optimize the production with the Box-Behnken design of experiment. The most optimal formulation was further combined with penetration enhancers to improve bioavailability of the active ingredient, and the in vitro drug release and in vitro permeation of BGP-15 from the patches were investigated. FTIR spectra of BGP-15, the formulations and the components were also studied. The most optimal formulation based on the tested parameters was dried for 24 h, with 67% polyvinyl alcohol (PVA) content and low ethanol content. The selected penetration enhancer excipients were not cytotoxic on HaCaT cells. The FTIR measurements and SEM photography proved the compatibility of the active substance and the vehicle; BGP-15 was present in the polymer matrix in dissolved form. The bioavailability of BGP-15 was most significantly enhanced by the combination of Transcutol and Labrasol. The in vitro permeation study confirmed that the formulated patches successfully enabled the transdermal administration of BGP-15.
Collapse
Affiliation(s)
- Ildikó Bácskay
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, 4032 Debrecen, Hungary
- Institute of Healthcare Industry, University of Debrecen, Nagyerdei körút 98, 4032 Debrecen, Hungary
| | - Zsolt Hosszú
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, 4032 Debrecen, Hungary
| | - István Budai
- Faculty of Engineering, University of Debrecen, Ótemető Utca 2-4, 4028 Debrecen, Hungary
| | - Zoltán Ujhelyi
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, 4032 Debrecen, Hungary
| | - Pálma Fehér
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, 4032 Debrecen, Hungary
| | - Dóra Kósa
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, 4032 Debrecen, Hungary
- Institute of Healthcare Industry, University of Debrecen, Nagyerdei körút 98, 4032 Debrecen, Hungary
| | - Ádám Haimhoffer
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, 4032 Debrecen, Hungary
- Institute of Healthcare Industry, University of Debrecen, Nagyerdei körút 98, 4032 Debrecen, Hungary
| | - Ágota Pető
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, 4032 Debrecen, Hungary
- Institute of Healthcare Industry, University of Debrecen, Nagyerdei körút 98, 4032 Debrecen, Hungary
| |
Collapse
|
4
|
Pető Á, Kósa D, Haimhoffer Á, Nemes D, Fehér P, Ujhelyi Z, Vecsernyés M, Váradi J, Fenyvesi F, Frum A, Gligor FG, Vicaș LG, Marian E, Jurca T, Pallag A, Muresan ME, Tóth Z, Bácskay I. Topical Dosage Formulation of Lyophilized Philadelphus coronarius L. Leaf and Flower: Antimicrobial, Antioxidant and Anti-Inflammatory Assessment of the Plant. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27092652. [PMID: 35566001 PMCID: PMC9100982 DOI: 10.3390/molecules27092652] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Revised: 04/14/2022] [Accepted: 04/15/2022] [Indexed: 12/12/2022]
Abstract
Philadelphus coronarius is a versatile plant and its use in folk medicine has a long tradition; however, scientifically, the medical utilization of the herb is a less explored research field. The aim of our study was to identify and determine the quantity of the bioactive compounds of both the leaf and the flower and prepare a lyophilized product of them, from which medical ointments were formulated, since the topical application of P. coronarius has also not been studied. In vitro drug release, texture analysis and biocompatibility experiments were carried out, as well as the investigation of microbiological, antioxidant and anti-inflammatory properties. According to our results the composition and the selected excipients of the ointments have a great impact on the drug release, texture and bioavailability of the preparation. During the microbiological testing, the P. coronarius leaf was effective against Escherichia coli and Staphylococcus aureus, but it did not significantly decrease IL-4 production when it was tested on HaCaT cells. P. coronarius is a promising herb, and its topical application in antimicrobial therapy can be a useful addition to modern medical therapy.
Collapse
Affiliation(s)
- Ágota Pető
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary; (Á.P.); (D.K.); (Á.H.); (D.N.); (P.F.); (Z.U.); (M.V.); (J.V.); (F.F.)
- Doctoral School of Pharmaceutical Sciences, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary
- Institute of Healthcare Industry, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary
| | - Dóra Kósa
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary; (Á.P.); (D.K.); (Á.H.); (D.N.); (P.F.); (Z.U.); (M.V.); (J.V.); (F.F.)
- Doctoral School of Pharmaceutical Sciences, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary
- Institute of Healthcare Industry, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary
| | - Ádám Haimhoffer
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary; (Á.P.); (D.K.); (Á.H.); (D.N.); (P.F.); (Z.U.); (M.V.); (J.V.); (F.F.)
- Doctoral School of Pharmaceutical Sciences, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary
| | - Dániel Nemes
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary; (Á.P.); (D.K.); (Á.H.); (D.N.); (P.F.); (Z.U.); (M.V.); (J.V.); (F.F.)
| | - Pálma Fehér
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary; (Á.P.); (D.K.); (Á.H.); (D.N.); (P.F.); (Z.U.); (M.V.); (J.V.); (F.F.)
| | - Zoltán Ujhelyi
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary; (Á.P.); (D.K.); (Á.H.); (D.N.); (P.F.); (Z.U.); (M.V.); (J.V.); (F.F.)
| | - Miklós Vecsernyés
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary; (Á.P.); (D.K.); (Á.H.); (D.N.); (P.F.); (Z.U.); (M.V.); (J.V.); (F.F.)
| | - Judit Váradi
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary; (Á.P.); (D.K.); (Á.H.); (D.N.); (P.F.); (Z.U.); (M.V.); (J.V.); (F.F.)
| | - Ferenc Fenyvesi
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary; (Á.P.); (D.K.); (Á.H.); (D.N.); (P.F.); (Z.U.); (M.V.); (J.V.); (F.F.)
| | - Adina Frum
- Faculty of Medicine, Lucian Blaga University Sibiu, Lucian Blaga Street, No 2A, H-550169 Sibiu, Romania; (A.F.); (F.G.G.)
| | - Felicia Gabriela Gligor
- Faculty of Medicine, Lucian Blaga University Sibiu, Lucian Blaga Street, No 2A, H-550169 Sibiu, Romania; (A.F.); (F.G.G.)
| | - Laura Grațiela Vicaș
- Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 29 Nicolae Jiga Street, H-410028 Oradea, Romania; (L.G.V.); (E.M.); (T.J.); (A.P.)
| | - Eleonora Marian
- Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 29 Nicolae Jiga Street, H-410028 Oradea, Romania; (L.G.V.); (E.M.); (T.J.); (A.P.)
| | - Tunde Jurca
- Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 29 Nicolae Jiga Street, H-410028 Oradea, Romania; (L.G.V.); (E.M.); (T.J.); (A.P.)
| | - Annamaria Pallag
- Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 29 Nicolae Jiga Street, H-410028 Oradea, Romania; (L.G.V.); (E.M.); (T.J.); (A.P.)
| | - Mariana Eugenia Muresan
- Department of Preclinical Discipline, Faculty of Medicine and Pharmacy, University of Oradea, 1st December Square 10, H-410068 Oradea, Romania;
| | - Zoltán Tóth
- Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary;
| | - Ildikó Bácskay
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary; (Á.P.); (D.K.); (Á.H.); (D.N.); (P.F.); (Z.U.); (M.V.); (J.V.); (F.F.)
- Institute of Healthcare Industry, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary
- Correspondence: ; Tel.: +36-52-411-717 (ext. 54034)
| |
Collapse
|
5
|
Vlaia L, Olariu I, Muţ AM, Coneac G, Vlaia V, Anghel DF, Maxim ME, Stângă G, Dobrescu A, Suciu M, Szabadai Z, Lupuleasa D. New, Biocompatible, Chitosan-Gelled Microemulsions Based on Essential Oils and Sucrose Esters as Nanocarriers for Topical Delivery of Fluconazole. Pharmaceutics 2021; 14:75. [PMID: 35056971 PMCID: PMC8778122 DOI: 10.3390/pharmaceutics14010075] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Revised: 12/06/2021] [Accepted: 12/27/2021] [Indexed: 01/11/2023] Open
Abstract
Biocompatible gel microemulsions containing natural origin excipients are promising nanocarrier systems for the safe and effective topical application of hydrophobic drugs, including antifungals. Recently, to improve fluconazole skin permeation, tolerability and therapeutic efficacy, we developed topical biocompatible microemulsions based on cinnamon, oregano or clove essential oil (CIN, ORG or CLV) as the oil phase and sucrose laurate (D1216) or sucrose palmitate (D1616) as surfactants, excipients also possessing intrinsic antifungal activity. To follow up this research, this study aimed to improve the adhesiveness of respective fluconazole microemulsions using chitosan (a biopolymer with intrinsic antifungal activity) as gellator and to evaluate the formulation variables' effect (composition and concentration of essential oil, sucrose ester structure) on the gel microemulsions' (MEGELs) properties. All MEGELs were evaluated for drug content, pH, rheological behavior, viscosity, spreadability, in vitro drug release and skin permeation and antifungal activity. The results showed that formulation variables determined distinctive changes in the MEGELs' properties, which were nevertheless in accordance with official requirements for semisolid preparations. The highest flux and release rate values and large diameters of the fungal growth inhibition zone were produced by formulations MEGEL-FZ-D1616-CIN 10%, MEGEL-FZ-D1216-CIN 10% and MEGEL-FZ-D1616-ORG 10%. In conclusion, these MEGELs were demonstrated to be effective platforms for fluconazole topical delivery.
Collapse
Affiliation(s)
- Lavinia Vlaia
- Department II—Pharmaceutical Technology, Formulation and Technology of Drugs Research Center, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania; (L.V.); (I.O.); (A.M.M.); (G.C.)
| | - Ioana Olariu
- Department II—Pharmaceutical Technology, Formulation and Technology of Drugs Research Center, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania; (L.V.); (I.O.); (A.M.M.); (G.C.)
| | - Ana Maria Muţ
- Department II—Pharmaceutical Technology, Formulation and Technology of Drugs Research Center, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania; (L.V.); (I.O.); (A.M.M.); (G.C.)
| | - Georgeta Coneac
- Department II—Pharmaceutical Technology, Formulation and Technology of Drugs Research Center, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania; (L.V.); (I.O.); (A.M.M.); (G.C.)
| | - Vicenţiu Vlaia
- Department I—Organic Chemistry, Formulation and Technology of Drugs Research Center, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania
| | - Dan Florin Anghel
- “Ilie Murgulescu” Institute of Physical Chemistry of the Romanian Academy, Laboratory of Colloid Chemistry, 060021 Bucharest, Romania; (D.F.A.); (M.E.M.); (G.S.)
| | - Monica Elisabeta Maxim
- “Ilie Murgulescu” Institute of Physical Chemistry of the Romanian Academy, Laboratory of Colloid Chemistry, 060021 Bucharest, Romania; (D.F.A.); (M.E.M.); (G.S.)
| | - Gabriela Stângă
- “Ilie Murgulescu” Institute of Physical Chemistry of the Romanian Academy, Laboratory of Colloid Chemistry, 060021 Bucharest, Romania; (D.F.A.); (M.E.M.); (G.S.)
| | - Amadeus Dobrescu
- Department X Surgery 2–Surgery 2, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania;
| | - Maria Suciu
- Department II—Pharmacology and Pharmacotherapy, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania;
| | - Zoltan Szabadai
- National Institute for Research and Development in Electrochemistry and Condensed Matter, 300569 Timişoara, Romania;
| | - Dumitru Lupuleasa
- Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, Romania;
| |
Collapse
|
6
|
Nicotinic Amidoxime Derivate BGP-15, Topical Dosage Formulation and Anti-Inflammatory Effect. Pharmaceutics 2021; 13:pharmaceutics13122037. [PMID: 34959318 PMCID: PMC8707203 DOI: 10.3390/pharmaceutics13122037] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Revised: 11/24/2021] [Accepted: 11/25/2021] [Indexed: 12/19/2022] Open
Abstract
BGP-15 is a Hungarian-developed drug candidate with numerous beneficial effects. Its potential anti-inflammatory effect is a common assumption, but it has not been investigated in topical formulations yet. The aim of our study was to formulate 10% BGP-15 creams with different penetration enhancers to ensure good drug delivery, improve bioavailability of the drug and investigate the potential anti-inflammatory effect of BGP-15 creams in vivo. Since the exact mechanism of the effect is still unknown, the antioxidant effect (tested with UVB radiation) and the ability of BGP-15 to decrease macrophage activation were evaluated. Biocompatibility investigations were carried out on HaCaT cells to make sure that the formulations and the selected excipients can be safely used. Dosage form studies were also completed with texture analysis and in vitro release with Franz diffusion chamber apparatus. Our results show that the ointments were able to reduce the extent of local inflammation in mice, but the exact mechanism of the effect remains unknown since BGP-15 did not show any antioxidant effect, nor was it able to decrease LPS-induced macrophage activation. Our results support the hypothesis that BGP-15 has a potential anti-inflammatory effect, even if it is topically applied, but the mechanism of the effect remains unclear and requires further pharmacological studies.
Collapse
|
7
|
Jaipakdee N, Jarukamjorn K, Putalun W, Limpongsa E. Permeation, stability and acute dermal irritation of miroestrol and deoxymiroestrol from Pueraria candollei var. mirifica crude extract loaded transdermal gels. Pharm Dev Technol 2021; 26:967-977. [PMID: 34382493 DOI: 10.1080/10837450.2021.1967982] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
In this study, permeation behaviors and chemical stability of miroestrol and deoxymiroestrol from Pueraria candollei var. mirifica (PM), Thai traditional medicine, crude extract containing transdermal gels were firstly evaluated. Three different PM extract containing gels were formulated, including hydroalcoholic and microemulsion gels using carbomer, and silicone gel using silicone elastomer. In vitro permeation through porcine ear skin demonstrated that the flux and 24 h cumulative permeation of miroestrol and deoxymiroestrol were in the order of hydroalcoholic > silicone > microemulsion gels. Hydroalcoholic gel provided the highest partition coefficient from gel onto skin, and thus the skin permeability coefficient. After 24 h permeation, no miroestrol and deoxymiroestrol remained deposited in the skin. Accelerated study using heating-cooling revealed insignificant difference between the remaining percentages of miroestrol and deoxymiroestrol in aqueous and non-aqueous based gels. Long-term stability study showed that miroestrol contents remained constant for 90 d and 30 d under 5 ± 3 °C and 30 ± 2 °C, 75 ± 5%RH, respectively; whereas the percentage of deoxymiroestrol decreased significantly after 30 d storage, irrespective of storage conditions. Acute dermal irritation test on New Zealand White rabbits showed that PM hydroalcoholic gels were non-irritant, with no signs of erythema or oedema.[Figure: see text].
Collapse
Affiliation(s)
- Napaphak Jaipakdee
- Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.,Center for Research and Development of Herbal Health Products (CRD-HHP), Khon Kaen University, Khon Kaen, Thailand
| | - Kanokwan Jarukamjorn
- Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.,Research Group for Pharmaceutical Activities of Natural Products using Pharmaceutical Biotechnology (PANPB), National Research University-Khon Kaen University, Khon Kaen, Thailand
| | - Waraporn Putalun
- Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.,Research Group for Pharmaceutical Activities of Natural Products using Pharmaceutical Biotechnology (PANPB), National Research University-Khon Kaen University, Khon Kaen, Thailand
| | - Ekapol Limpongsa
- Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.,College of Pharmacy, Rangsit University, Pathumthani, Thailand
| |
Collapse
|
8
|
Development of Microemulsions Containing Glochidion wallichianum Leaf Extract and Potential for Transdermal and Topical Skin Delivery of Gallic Acid. Sci Pharm 2020. [DOI: 10.3390/scipharm88040053] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
Abstract
Glochidion wallichianum (GW) is a good source of antioxidants, including gallic acid, promoting its development as a microemulsion. We constructed five pseudo-ternary phase diagrams comprising isopropyl myristate (IPM), water, and surfactant mixture (Smix)—i.e., Labrasol®:HCO-40® (1:1) with Transcutol® (1:1, 2:1, 3:1), and Tween80:Span80 (3:2) with Transcutol® or propylene glycol:ethanol (1:1). Additionally, blank and GW extract-loaded microemulsions were prepared at an IPM:Water:Smix ratio of 10:30:60 (high water content) and 30:10:60 (high oil content) from each Smix. The physical characteristics, skin permeation, and disposition were evaluated. The formulations with high water content and conductivities provided higher gallic acid permeation and disposition than those with high oil content. The Smix of Labrasol®:HCO-40® (1:1) and Transcutol® (1:1) promoted the highest gallic acid permeation (enhancement ratio 1.78 ± 0.12) and was suitable for transdermal delivery. However, the 1% hydroxypropyl methylcellulose control gel, the microemulsion with Smix of Labrasol®:HCO-40® (1:1) with Transcutol® (2:1), and Smix of Tween80:Span80 (3:2) with propylene glycol:ethanol (1:1) could provide higher skin accumulation of gallic acid than that with other formulations. The microstructures, ratio of surfactant:cosurfactant, and compositions of microemulsions were found to affect the skin permeation and disposition of gallic acid and require optimization to act as transdermal or topical delivery carriers.
Collapse
|
9
|
Formulation of Creams Containing Spirulina Platensis Powder with Different Nonionic Surfactants for the Treatment of Acne Vulgaris. Molecules 2020; 25:molecules25204856. [PMID: 33096785 PMCID: PMC7587940 DOI: 10.3390/molecules25204856] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2020] [Revised: 10/16/2020] [Accepted: 10/19/2020] [Indexed: 11/24/2022] Open
Abstract
Natural products used in the treatment of acne vulgaris may be promising alternative therapies with fewer side effects and without antibiotic resistance. The objective of this study was to formulate creams containing Spirulina (Arthrospira) platensis to be used in acne therapy. Spirulina platensis belongs to the group of micro algae and contains valuable active ingredients. The aim was to select the appropriate nonionic surfactants for the formulations in order to enhance the diffusion of the active substance and to certify the antioxidant and antibacterial activity of Spirulina platensis-containing creams. Lyophilized Spirulina platensis powder (SPP) was dissolved in Transcutol HP (TC) and different types of nonionic surfactants (Polysorbate 60 (P60), Cremophor A6:A25 (CR) (1:1), Tefose 63 (TFS), or sucrose ester SP 70 (SP70)) were incorporated in creams as emulsifying agents. The drug release was evaluated by the Franz diffusion method and biocompatibility was tested on HaCaT cells. In vitro antioxidant assays were also performed, and superoxide dismutase (SOD) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) assays were executed. Antimicrobial activities of the selected compositions were checked against Staphylococcus aureus (S. aureus) and Cutibacteriumacnes (C. acnes) (formerly Propionibacterium acnes) with the broth microdilution method. Formulations containing SP 70 surfactant with TC showed the most favorable dissolution profiles and were found to be nontoxic. This composition also showed significant increase in free radical scavenger activity compared to the blank sample and the highest SOD enzyme activity was also detected after treatment with the cream samples. In antibacterial studies, significant differences were observed between the treated and control groups after an incubation time of 6 h.
Collapse
|
10
|
Neupane R, Boddu SH, Renukuntla J, Babu RJ, Tiwari AK. Alternatives to Biological Skin in Permeation Studies: Current Trends and Possibilities. Pharmaceutics 2020; 12:E152. [PMID: 32070011 PMCID: PMC7076422 DOI: 10.3390/pharmaceutics12020152] [Citation(s) in RCA: 200] [Impact Index Per Article: 40.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2020] [Revised: 02/10/2020] [Accepted: 02/10/2020] [Indexed: 12/17/2022] Open
Abstract
: The transdermal route of drugs has received increased attention in recent years due to numerous advantages over the oral and injectable routes, such as avoidance of the hepatic metabolism, protection of drugs from the gastrointestinal tract, sustained drug delivery, and good patient compliance. The assessment of ex vivo permeation during the pharmaceutical development process helps in understanding the product quality and performance of a transdermal delivery system. Generally, excised human skin relevant to the application site or animal skin is recommended for ex vivo permeation studies. However, the limited availability of the human skin and ethical issues surrounding the use of animal skin rendered these models less attractive in the permeation study. In the last three decades, enormous efforts have been put into developing artificial membranes and 3D cultured human skin models as surrogates to the human skin. This manuscript provides an insight on the European Medicines Agency (EMA) guidelines for permeation studies and the parameters affected when using Franz diffusion cells in the permeation study. The need and possibilities for skin alternatives, such as artificially cultured human skin models, parallel artificial membrane permeability assays (PAMPA), and artificial membranes for penetration and permeation studies, are comprehensively discussed.
Collapse
Affiliation(s)
- Rabin Neupane
- Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA; (R.N.); (A.K.T.)
| | - Sai H.S. Boddu
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman 346, UAE;
| | - Jwala Renukuntla
- Department of Pharmaceutical Sciences, School of Pharmacy, High Point University, High Point, NC 27240, USA
| | - R. Jayachandra Babu
- Department of Drug Discovery and Development, Auburn University, Auburn, AL 36849, USA;
| | - Amit K. Tiwari
- Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA; (R.N.); (A.K.T.)
| |
Collapse
|
11
|
Novel Nanocarriers for Targeted Topical Skin Delivery of the Antioxidant Resveratrol. Pharmaceutics 2020; 12:pharmaceutics12020108. [PMID: 32013204 PMCID: PMC7076350 DOI: 10.3390/pharmaceutics12020108] [Citation(s) in RCA: 30] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2019] [Revised: 01/20/2020] [Accepted: 01/26/2020] [Indexed: 12/20/2022] Open
Abstract
Resveratrol (RSV) is a potent lipophilic antioxidant with a low aqueous solubility. Novel nanoformulations have been successfully developed and evaluated to increase the potential of resveratrol as a skin targeting antioxidant. Nanoformulations were prepared using a spontaneous emulsification method, and characterized and evaluated for their capabilities to penetrate/permeate the skin. In nanoformulations, the thermodynamic activity of the RSV penetration into/permeation through the skin was correlated with the thermodynamic activity of the RSV in the formulations. When terpenes were incorporated into the nanoformulations, the permeation of RSV through the skin increased and correlated with an increasing lipophilicity of the terpene. The nanoemulsion containing eugenol showed the highest RSV penetration into the stratum corneum (SC) and the epidermis-dermis-follicle region, whereas the limonene containing nanoemulsion had the highest RSV permeation through the skin (the enhancement ratios, compared to a saturated solution of RSV, were (i) 9.55 and (ii) 12.61, respectively, based on the average RSV amount (i) in each skin region and (ii) permeation through skin).
Collapse
|
12
|
Jameel BM, Huynh A, Chadha A, Pandey S, Duncan J, Chandler M, Baki G. Computer-based formulation design and optimization using Hansen solubility parameters to enhance the delivery of ibuprofen through the skin. Int J Pharm 2019; 569:118549. [PMID: 31394188 DOI: 10.1016/j.ijpharm.2019.118549] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2019] [Revised: 07/09/2019] [Accepted: 07/19/2019] [Indexed: 10/26/2022]
Abstract
Trial-and-error approach to formulation development is long and costly. With growing time and cost pressures in the pharmaceutical industry, the need for computer-based formulation design is greater than ever. In this project, emulgels were designed and optimized using Formulating for Efficacy™ (FFE) for the topical delivery of ibuprofen. FFE helped select penetration enhancers, design and optimize emulgels and simulate skin penetration studies. pH, viscosity, spreadability, droplet size and stability of emulgels were evaluated. Franz cell studies were performed to test in vitro drug release on regenerated cellulose membrane, drug permeation in vitro on Strat-M® membrane and ex vivo on porcine ear skin, a marketed ibuprofen gel served as control. Emulgels had skin compatible pH, viscosity and spreadability comparable to a marketed emulgel, were opaque and stable at 25 °C for 6 months. Oleyl alcohol (OA), combined with either dimethyl isosorbide (DMI) or diethylene glycol monoethyl ether (DGME) provided the highest permeation in 24 h in vitro, which was significantly higher than the marketed product (p < 0.01). OA + DGME significantly outperformed OA ex vivo (p < 0.05). The computer predictions, in vitro and ex vivo penetration results correlated well. FFE was a fast, valuable and reliable tool for aiding in topical product design for ibuprofen.
Collapse
Affiliation(s)
- Bshaer M Jameel
- The University of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice, 3000 Arlington Ave, Toledo, OH 43614, United States.
| | - An Huynh
- The University of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice, 3000 Arlington Ave, Toledo, OH 43614, United States.
| | - Aastha Chadha
- The University of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice, 3000 Arlington Ave, Toledo, OH 43614, United States
| | - Sujata Pandey
- The University of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice, 3000 Arlington Ave, Toledo, OH 43614, United States.
| | - Jacalyn Duncan
- The University of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice, 3000 Arlington Ave, Toledo, OH 43614, United States.
| | - Mark Chandler
- ACT Solutions Corp, 550 S. College Ave., Suite 110, Newark, DE 19713, United States.
| | - Gabriella Baki
- The University of Toledo, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice, 3000 Arlington Ave, Toledo, OH 43614, United States.
| |
Collapse
|
13
|
Aggregation properties of sucrose fatty acid esters and some other sugar-based surfactants at different temperatures. J Mol Liq 2018. [DOI: 10.1016/j.molliq.2018.09.013] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
14
|
Zhengguang L, Jie H, Yong Z, Jiaojiao C, Xingqi W, Xiaoqin C. Study on the transdermal penetration mechanism of ibuprofen nanoemulsions. Drug Dev Ind Pharm 2018; 45:465-473. [DOI: 10.1080/03639045.2018.1546317] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- Li Zhengguang
- Department of Pharmaceutics, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
| | - Huang Jie
- Department of Pharmaceutics, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
| | - Zhang Yong
- Department of Pharmaceutics, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
| | - Cao Jiaojiao
- Department of Pharmaceutics, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
| | - Wang Xingqi
- Department of Pharmaceutics, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
| | - Chu Xiaoqin
- Department of Pharmaceutics, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
- Institute of Pharmaceutics, Anhui Academy of Chinese Medical Sciences, Hefei, China
| |
Collapse
|
15
|
Osborne DW, Musakhanian J. Skin Penetration and Permeation Properties of Transcutol®-Neat or Diluted Mixtures. AAPS PharmSciTech 2018; 19:3512-3533. [PMID: 30421383 PMCID: PMC6848246 DOI: 10.1208/s12249-018-1196-8] [Citation(s) in RCA: 120] [Impact Index Per Article: 17.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2018] [Accepted: 09/24/2018] [Indexed: 01/14/2023] Open
Abstract
A heightened interest in (trans)dermal delivery is in part driven by the need to improve the existing skin therapies and also the demand for alternative routes of administration, notably for pharmaceutical actives with undesirable oral absorption characteristics. The premise of delivering difficult actives to the skin or via the skin however is weighed down by the barrier function properties of the stratum corneum. Short of disrupting the skin by physical means, scientists have resorted to formulation with excipients known to enhance the skin penetration and permeation of drugs. A vehicle that has emerged over the years as a safe solubilizer and enhancer for a broad range of drug actives is the highly purified NF/EP grade of diethylene glycol monoethyl ether (DEGEE) commercially known as Transcutol®. Whereas numerous studies affirm its enhancing effect on drug solubilization, percutaneous absorption rate, and/or drug retention in the skin, there are few publications that unite the body of the published literature in describing the precise role and mechanisms of action for Transcutol®. In view of the current mechanistic understanding of skin barrier properties, this paper takes on a retrospective review of the published works and critically evaluates the data for potential misses due to experimental variables such as formulation design, skin model, skin hydration levels, and drug properties. The goal of this review is to mitigate the incongruence of the published works and to construct a unified, comprehensive understanding of how Transcutol® influences skin penetration and permeation. Graphical Abstract Transcutol has affinity for the hydrophilic head groups of the stratum corneum structures.
Collapse
|
16
|
Thermodynamic properties of disaccharide based surfactants adsorption at the water-air interface. Colloids Surf A Physicochem Eng Asp 2018. [DOI: 10.1016/j.colsurfa.2018.04.064] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
17
|
Zdziennicka A, Krawczyk J, Szymczyk K, Jańczuk B. Macroscopic and Microscopic Properties of Some Surfactants and Biosurfactants. Int J Mol Sci 2018; 19:E1934. [PMID: 29966385 PMCID: PMC6073259 DOI: 10.3390/ijms19071934] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2018] [Revised: 06/22/2018] [Accepted: 06/29/2018] [Indexed: 11/17/2022] Open
Abstract
The adsorption of surfactants at the water-air and solid-water interfaces and their wetting properties decide their practical applications. Therefore the adsorption of monorhamnolipid, surfactin, n-octyl-β-d-glucopyranoside, n-dodecyl-β-d-glucopyranoside, n-dodecyl-β-d-maltoside, sucrose monodecanoate, sucrose monododecanoate, Tween 20, Tween 60, and Tween 80 at the water-air, polytetrafluoroethylene-water, polyethylene-water, poly(methyl methacrylate)-water, polyamide-water, and quartz-water interfaces, their tendency to form micelles as well as their wetting properties, were considered in the light of their microscopic properties. For this purpose, the components and parameters of the surfactant tail and head, water and solids surface tension, and surfactant contactable area with adherent medium were applied for prediction of surfactant-surfactant and surfactant-solid interactions through the water phase with regard to their adsorption, micellization, and wetting processes. Next, the Gibbs free energy of interactions was compared to the Gibbs free energy of surfactant adsorption at the water-air and solid-water interfaces as well as the micellization. It appeared that from the surfactant-surfactant and surfactant-solid interactions through the water phase determined on the basis of the tail and head of surfactant surface tension, it is possible to predict the surfactant tendency to adsorb at the water-air and solid-water interfaces, as well as to form micelles.
Collapse
Affiliation(s)
- Anna Zdziennicka
- Department of Interfacial Phenomena, Faculty of Chemistry, Maria Curie-Skłodowska University, Maria Curie-Skłodowska Sq. 3, 20-031 Lublin, Poland.
| | - Joanna Krawczyk
- Department of Interfacial Phenomena, Faculty of Chemistry, Maria Curie-Skłodowska University, Maria Curie-Skłodowska Sq. 3, 20-031 Lublin, Poland.
| | - Katarzyna Szymczyk
- Department of Interfacial Phenomena, Faculty of Chemistry, Maria Curie-Skłodowska University, Maria Curie-Skłodowska Sq. 3, 20-031 Lublin, Poland.
| | - Bronisław Jańczuk
- Department of Interfacial Phenomena, Faculty of Chemistry, Maria Curie-Skłodowska University, Maria Curie-Skłodowska Sq. 3, 20-031 Lublin, Poland.
| |
Collapse
|
18
|
Effects of sucrose ester structures on liposome-mediated gene delivery. Acta Biomater 2018; 72:278-286. [PMID: 29609051 DOI: 10.1016/j.actbio.2018.03.031] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2017] [Revised: 02/19/2018] [Accepted: 03/15/2018] [Indexed: 12/12/2022]
Abstract
Sucrose esters (SEs) have great potential applications in gene delivery because of their low toxicity, excellent biocompatibility, and biodegradability. By using tripeptide-based lipid (CDO) as a model lipid and SEs as helper lipids, a series of liposomes were prepared. The SEs with hydrophilic-lipophilic balance (HLB) values of 1, 6, 11, or 16 and the fatty acids of laurate, stearate, or oleate were used in the liposomes. We investigated the effect of HLB values of SEs and fatty acid types on gene transfection efficiency and toxicity of liposomes. The results showed that transfection efficiencies of the liposomes containing SEs with HLB value of 6 were superior to other liposomes in HeLa, MCF-7, NCI-H460, and A549 tumor cells. For the same HLB value, liposomes of laurate SEs were preferable to transfect cells compared to SEs of stearate and oleate. The liposomes with SEs showed higher cellular uptake than liposome without SEs (LipoCDO). LipoL12-6/Luc-siRNA treatment on tumor-bearing mice exhibited about 60% in vivo gene silencing of luciferase, and LipoL12-6 could mediate IGF-1R siRNA to greatly inhibit tumor growth. Moreover, liposomes with SEs revealed remarkably low toxicity in vitro and in vivo. The illustration of SE structures on gene delivery will promote the use of SEs for clinical trials of liposomes. STATEMENT OF SIGNIFICANCE This article is the first to study the effects of various chain lengths and hydrophilic-lipophilic balance (HLB) of sucrose esters (SEs) on gene transfection efficiency and safety of liposomes for gene delivery. The in vitro delivery of pDNA and siRNA by lipoplexes against HeLa, MCF-7, NCI-H460, and A549 tumor cells showed that the lipoplexes could lead to better transfection and lower cytotoxicity after the addition of SEs. SEs with shorter chain and a median HLB value could provide the liposomes with much higher gene transfection efficiency than others. The in vivo delivery of siRNA to tumor-bearing mice further confirmed that liposome containing laurate SE (LipoL12-6) could be a potential therapeutic vector, as it delivered siRNA to silence nearly 60% of the luciferase in tumors and also greatly inhibited the tumor growth. Therefore, the addition of SEs to liposomes proved to be relatively safe in vitro and in vivo. These preliminary results demonstrated that SEs show great potential for constructing controlled-release systems for gene delivery. The readers will get insights into a series of gene vectors and deepen their understanding about gene delivery.
Collapse
|
19
|
The effect of the antioxidant on the properties of thiolated poly(aspartic acid) polymers in aqueous ocular formulations. Eur J Pharm Biopharm 2017; 113:178-187. [DOI: 10.1016/j.ejpb.2016.12.026] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2016] [Revised: 11/29/2016] [Accepted: 12/06/2016] [Indexed: 11/20/2022]
|
20
|
Sucrose ester based cationic liposomes as effective non-viral gene vectors for gene delivery. Colloids Surf B Biointerfaces 2016; 145:454-461. [DOI: 10.1016/j.colsurfb.2016.05.033] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2016] [Revised: 04/16/2016] [Accepted: 05/11/2016] [Indexed: 01/01/2023]
|
21
|
Balázs B, Vizserálek G, Berkó S, Budai-Szűcs M, Kelemen A, Sinkó B, Takács-Novák K, Szabó-Révész P, Csányi E. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane. J Pharm Sci 2016; 105:1134-40. [DOI: 10.1016/s0022-3549(15)00172-0] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2015] [Revised: 10/27/2015] [Accepted: 11/19/2015] [Indexed: 10/22/2022]
|
22
|
Horvát G, Budai-Szűcs M, Berkó S, Szabó-Révész P, Soós J, Facskó A, Maroda M, Mori M, Sandri G, Bonferoni MC, Caramella C, Csányi E. Comparative study of nanosized cross-linked sodium-, linear sodium- and zinc-hyaluronate as potential ocular mucoadhesive drug delivery systems. Int J Pharm 2015; 494:321-8. [DOI: 10.1016/j.ijpharm.2015.08.024] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2015] [Revised: 08/05/2015] [Accepted: 08/08/2015] [Indexed: 11/26/2022]
|
23
|
Balázs B, Csizmazia E, Berkó S, Budai-Szűcs M, Szabó-Révész P, Csányi E. New Approach of Sucrose Myristate as a Promising Penetration Enhancer in Dermal Preparations. TENSIDE SURFACT DET 2015. [DOI: 10.3139/113.110388] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
AbstractThe aim of this work was to compare the penetration enhancer effect of newly developed sucrose myristate with the generally used sucrose laurate. Hydrogel formulations containing sucrose esters (SEs) were prepared and the model drug was Ibuprofen (IBU), which has oral side effects, so applying it in a transdermal system could be useful. We evaluated the effect of SE hydrogel formulations on the skin by the noninvasive in vivo test and examined their concentration dependent influence on the penetration of IBU through a synthetic membrane (in vitro) by the Franz cell method. The results indicated that sucrose myristate incorporated into hydrogel moistures the skin well and lastingly and showed a better drug penetration enhancing effect at a much lower concentration compared to sucrose laurate. Our results revealed that sucrose myristate could be a promising and effective penetration enhancer in the pharmaceutical field.
Collapse
Affiliation(s)
- Boglárka Balázs
- 1University of Szeged, Department of Pharmaceutical Technology, Szeged, Hungary
- 2Gedeon Richter Plc., Budapest, Hungary
| | | | - Szilvia Berkó
- 1University of Szeged, Department of Pharmaceutical Technology, Szeged, Hungary
| | - Mária Budai-Szűcs
- 1University of Szeged, Department of Pharmaceutical Technology, Szeged, Hungary
| | | | - Erzsébet Csányi
- 1University of Szeged, Department of Pharmaceutical Technology, Szeged, Hungary
| |
Collapse
|
24
|
Thiolated poly(aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery system. Eur J Pharm Sci 2015; 67:1-11. [DOI: 10.1016/j.ejps.2014.10.013] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2014] [Revised: 10/17/2014] [Accepted: 10/18/2014] [Indexed: 11/21/2022]
|
25
|
Szűts A, Szabó-Révész P. Sucrose esters as natural surfactants in drug delivery systems--a mini-review. Int J Pharm 2012; 433:1-9. [PMID: 22575672 DOI: 10.1016/j.ijpharm.2012.04.076] [Citation(s) in RCA: 115] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2012] [Revised: 04/27/2012] [Accepted: 04/28/2012] [Indexed: 10/28/2022]
Abstract
Sucrose esters (SEs) are widely used in the food and cosmetic industries and there has recently been great interest in their applicability in different pharmaceutical fields. They are natural and biodegradable excipients with well-known emulsifying and solubilizing behavior. Currently the most common pharmaceutical applications of SEs are for the enhancement of drug dissolution and drug absorption/permeation, and in controlled-release systems. Although the number of articles on SEs is continuously increasing, they have not yet been widely used in the pharmaceutical industry. The aim of this review is to discuss and summarize some of the findings and applications of SEs in different areas of drug delivery. The article highlights the main properties of SEs and focuses on their use in pharmaceutical technology and on their regulatory and toxicological status.
Collapse
Affiliation(s)
- Angéla Szűts
- Department of Pharmaceutical Technology, University of Szeged, H-6720, Szeged, Eötvös u. 6, Hungary
| | | |
Collapse
|
26
|
Eros G, Hartmann P, Berkó S, Csizmazia E, Csányi E, Sztojkov-Ivanov A, Németh I, Szabó-Révész P, Zupkó I, Kemény L. A novel murine model for the in vivo study of transdermal drug penetration. ScientificWorldJournal 2012; 2012:543536. [PMID: 22272176 PMCID: PMC3259504 DOI: 10.1100/2012/543536] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2011] [Accepted: 11/02/2011] [Indexed: 11/17/2022] Open
Abstract
Enhancement of the transdermal penetration of different active agents is an important research goal. Our aim was to establish a novel in vivo experimental model which provides a possibility for exact measurement of the quantity of penetrated drug. The experiments were performed on SKH-1 hairless mice. A skin fold in the dorsal region was fixed with two fenestrated titanium plates. A circular wound was made on one side of the skin fold. A metal cylinder with phosphate buffer was fixed into the window of the titanium plate. The concentration of penetrated drug was measured in the buffer. The skin fold was morphologically intact and had a healthy microcirculation. The drug appeared in the acceptor buffer after 30 min, and its concentration exhibited a continuous increase. The presence of ibuprofen was also detected in the plasma. In conclusion, this model allows an exact in vivo study of drug penetration and absorption.
Collapse
Affiliation(s)
- Gábor Eros
- Department of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary.
| | | | | | | | | | | | | | | | | | | |
Collapse
|